1. A systematic review and pooled analysis of retrospective series of eribulin in metastatic breast cancer
   Ioannis A. Voutsadakis, 2017, Anti-Cancer Drugs CrossRef
2. Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience
   Eufemia S. Lutrino et al, 2020, Tumori Journal CrossRef